Related Experiment Video
Updated: Sep 28, 2025
08:50
How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
9.4K
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials.
Erica A Smith1,2,3,4,5,6,7,8,9,10,11, William P Horan1,2,3,4,5,6,7,8,9,10,11, Dominique Demolle1,2,3,4,5,6,7,8,9,10,11
1Drs. Smith and Demolle are with Cognivia in Mont St. Guibert, Belgium.
Innovations in Clinical Neuroscience
|April 6, 2022
Summary
Artificial intelligence (AI) and machine learning (ML) may offer solutions to manage the complex placebo response in clinical trials. This review explores AI/ML applications to improve drug development by addressing high placebo rates.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Pharmacology
- Data Science
Background:
- The placebo response is a complex psychosocial-biological phenomenon impacting drug development, especially in neurological and psychiatric diseases.
- Despite extensive research, effective strategies to manage high placebo response rates in clinical trials remain elusive.
- Advanced data analytics, including artificial intelligence (AI), show promise for addressing this challenge.
Purpose of the Study:
- To review the application of AI and machine learning (ML) for managing placebo response in drug development.
- To identify critical factors for applying AI/ML to placebo response challenges.
- To examine practical AI/ML use cases and regulatory considerations for clinical trials.
Main Methods:
- Literature review focusing on AI and ML techniques applied to placebo response.
- Analysis of critical factors for AI/ML implementation in clinical trial design.
- Exploration of regulatory aspects for integrating AI/ML into pharmaceutical research.
Main Results:
- AI and ML offer potential to mitigate negative impacts of high placebo response rates.
- Specific AI/ML techniques can be applied to analyze placebo effects and optimize trial outcomes.
- Consideration of regulatory frameworks is crucial for successful AI/ML integration.
Conclusions:
- AI and ML represent a promising frontier for tackling the long-standing placebo response issue in drug development.
- Strategic application of AI/ML can enhance the efficiency and reliability of clinical trials.
- Further research and regulatory guidance are needed to fully leverage AI/ML in pharmaceutical research.
Related Concept Videos
01:54The Placebo Effect
6.4K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.4K
01:11Blinding
3.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.3K
02:07Blind Procedures
12.3K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.3K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
186
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186
01:16Clinical Trials
9.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.4K
01:11Clinical Trials: Overview
3.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.5K